Company: LNAI
Filing Date: 2025-11-03
Form Type: 8-K
Source: 0001731122-25-001465
Chunk: 1

Company: Lunai Bioworks Inc.
Filing Date: 2025-11-03
Form: 8-K
Item: Item 5.07
Chunk 1
---
 and is in compliance with Nasdaq’s corporate governance and voting standards.

Accordingly,
stockholders elected all director nominees to hold office for terms expiring at the Company’s 2026 annual meeting of stockholders.

Proposal
2 Approval of Say-on-Pay Proposal

  For:                 5,548,091  
  Against:             2,182,131  
  Abstain:                11,760  
  Broker Non-Vote      1,314,903  

Accordingly,
stockholders approved by a non-biding advisory vote the compensation of the Company’s named executive officers.

Proposal
3:Approval of Independent Auditor

  For:                 8,836,759  
  Against:             18,002     
  Abstain:             202,124    
  Broker Non-Vote      —          

Accordingly,
stockholders approved by a non-biding advisory vote Sadler as the Company’s independent registered public accounting firm.

Proposal
3:Approval of Amendments to 2023 Equity Incentive Plan

  For:                 6,956,477  
  Against:               574,336  
  Abstain:               211,169  
  Broker Non-Vote      1,314,903  

Accordingly,
stockholders approved the amendments to the Company’s 2023 Equity Incentive Plan.

Item
9.01 Financial Statements and Exhibits.